At the Phase 1 Unit at KFUE, early studies, known as First-In-Human studies, as well as other Phase 1 studies and early Phase 2 studies on patients are conducted. The unit is inspected and approved by the Medical Products Agency and comprises research nurses, nursing assistants, and physicians.

Referring a Patient to a Phase 1 Study

Referrals to the Phase 1 Unit are sent to the Onkologmottagningen, Blod och Tumörsjukdomar, Akademiska sjukhuset, attention to KFUE. Incoming referrals are assessed by the referral assessment group, which consists of physicians and research nurses.

We evaluate referrals once a week. The patient should be contacted when the referral is sent to us. This information should be indicated in the medical record or the referral from your end. If necessary, additional information may be requested. If the patient is considered suitable for a study, we schedule a first appointment for the patient.

The following documentation should be included with the referral:

  • Patient's disease and general condition
  • Diagnosis and current disease extent
  • Summary of previous treatment
  • Past/Present illnesses
  • ECOG PS